Orphazyme publishes offering circular and the indicative offer price range for its IPO 06 November 2017
Orphazyme, a Danish biotech company with a late stage orphan drug pipeline, today published an offering... Read more
Orphazyme, a Danish biotech company with a late stage orphan drug pipeline, today published an offering... Read more
Det danske biotekselskab MonTa Biosciences har netop tegnet en licensaftale med UC San Diego Universitet... Read more
Orphazyme, a Danish biotech company with a late stage orphan drug pipeline, announces its intention to... Read more
Y-mAbs Therapeutics, Inc. closes $50 million in a private placement led by HBM Healthcare Investments... Read more
For nogle uger siden præsenterede regeringen sit erhvervs- og iværksætterudspil med 22 initiativer... Read more
Oral presentation of efficacy and safety data of Sym004 in refractory metastatic colorectal cancer Symphogen... Read more
Pan-Nordic mentor network NOME provides Nordic life science start-ups with the opportunity to present... Read more
Interesting EU project PERMIDES provides innovation vouchers for biopharma SMEs valued up to 60,000... Read more
Området for Personlig Medicin har potentialet til at blive et vigtigt dansk forskningsområde med lovende... Read more